These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11698342)

  • 21. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour ploidy in DNA histograms of pituitary adenomas.
    Lüdecke DK; Beck-Bornholdt HP; Saeger W; Schmidt W
    Acta Neurochir (Wien); 1985; 76(1-2):18-22. PubMed ID: 2988290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and clinical significance of Wnt players and survivin in pituitary tumours.
    Formosa R; Gruppetta M; Falzon S; Santillo G; DeGaetano J; Xuereb-Anastasi A; Vassallo J
    Endocr Pathol; 2012 Jun; 23(2):123-31. PubMed ID: 22327960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours.
    Antonini SR; Latronico AC; Elias LL; Cukiert A; Machado HR; Liberman B; Mendonca BB; Moreira AC; Castro M
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):657-62. PubMed ID: 12390341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
    Zhang YJ; Chen SY; Chen CJ; Santella RM
    Mol Carcinog; 2002 Feb; 33(2):125-9. PubMed ID: 11813305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
    Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
    Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
    Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
    J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA and S-phase representation in human growth hormone producing pituitary adenomas.
    Hulting AL; Tribukait B; Bergstrand G; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):295-303. PubMed ID: 4024848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC.
    Deng L; Zhao XR; Pan KF; Wang Y; Deng XY; Lü YY; Cao Y
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):16-20. PubMed ID: 11958128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
    Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
    Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
    Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.